Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $525.00 at Royal Bank of Canada

Intuitive Surgical (NASDAQ:ISRG) had its target price raised by Royal Bank of Canada from $515.00 to $525.00 in a research report released on Tuesday morning, Benzinga reports. The firm currently has an outperform rating on the medical equipment provider’s stock.

A number of other research analysts have also weighed in on ISRG. BTIG Research raised their price objective on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a buy rating in a research note on Wednesday, August 28th. Citigroup lifted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a buy rating in a research note on Thursday, August 22nd. Truist Financial increased their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the stock a buy rating in a research note on Tuesday, July 16th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $475.00 to $495.00 and gave the company an overweight rating in a research report on Friday, July 19th. Finally, Stifel Nicolaus increased their price target on Intuitive Surgical from $430.00 to $475.00 and gave the company a buy rating in a research report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of Moderate Buy and an average target price of $454.35.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $483.84 on Tuesday. The business has a 50-day simple moving average of $478.98 and a 200 day simple moving average of $433.69. Intuitive Surgical has a one year low of $254.85 and a one year high of $496.48. The firm has a market capitalization of $171.93 billion, a price-to-earnings ratio of 83.13, a PEG ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the previous year, the company posted $1.18 earnings per share. The company’s quarterly revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts expect that Intuitive Surgical will post 5.22 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 over the last ninety days. 0.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Koshinski Asset Management Inc. grew its stake in Intuitive Surgical by 6.3% during the third quarter. Koshinski Asset Management Inc. now owns 4,246 shares of the medical equipment provider’s stock valued at $2,086,000 after acquiring an additional 253 shares in the last quarter. Renaissance Investment Group LLC boosted its holdings in Intuitive Surgical by 0.5% in the 3rd quarter. Renaissance Investment Group LLC now owns 30,503 shares of the medical equipment provider’s stock valued at $14,985,000 after purchasing an additional 145 shares during the period. Inspire Investing LLC grew its position in shares of Intuitive Surgical by 2.1% during the 3rd quarter. Inspire Investing LLC now owns 32,718 shares of the medical equipment provider’s stock valued at $16,073,000 after purchasing an additional 667 shares in the last quarter. Ritholtz Wealth Management grew its position in shares of Intuitive Surgical by 14.1% during the 3rd quarter. Ritholtz Wealth Management now owns 4,421 shares of the medical equipment provider’s stock valued at $2,172,000 after purchasing an additional 546 shares in the last quarter. Finally, Bennett Selby Investments LP purchased a new stake in shares of Intuitive Surgical in the third quarter worth $212,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.